Seelos Therapeutics, Inc. (SEEL)

NASDAQ: SEEL · IEX Real-Time Price · USD

0.327

+0.001 (0.43%)

At close: Apr 23, 2024, 4:00 PM

0.330

+0.003 (0.89%)

After-hours: Apr 23, 2024, 7:36 PM EDT

Seelos Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Revenue	2.2	0	0	0	0.38	0	0	0	4.84	9.26	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-	-	-	-47.74%	268.74%	Upgrade
Cost of Revenue	0	0	0	0	0	0	0	0	0.92	0.92	Upgrade
Gross Profit	2.2	0	0	0	0.38	0	0	0	3.92	8.34	Upgrade
Selling, General & Admin	12.59	12.3	15.02	7.78	7.56	2.63	7.21	7.78	10.52	11.42	Upgrade
Research & Development	30.12	58.62	46.65	10.98	22.56	0.55	3.46	5.88	14.65	21.29	Upgrade
Other Operating Expenses	0	0	0	0	0	0	0	0.01	0.1	-1.76	Upgrade
Operating Expenses	42.7	70.92	61.67	18.76	30.12	3.18	10.68	13.67	25.27	30.95	Upgrade
Operating Income	-40.5	-70.92	-61.67	-18.76	-29.75	-3.18	-10.68	-13.67	-21.35	-22.61	Upgrade
Interest Expense / Income	0.08	0.01	1.6	0.16	0.03	0.13	0.08	0.98	0.9	0.34	Upgrade
Other Expense / Income	-2.69	2.6	2.78	0.18	21.48	0.16	-11.08	-7.22	-3.22	-1.16	Upgrade
Pretax Income	-37.88	-73.53	-66.05	-19.1	-51.26	-3.48	0.32	-7.43	-19.02	-21.79	Upgrade
Net Income	-37.88	-73.53	-66.05	-19.1	-51.26	-3.48	0.32	-7.43	-19.02	-21.79	Upgrade
Shares Outstanding (Basic)	5	4	3	1	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	5	4	3	1	1	0	0	0	0	0	Upgrade
Shares Change	38.20%	17.03%	103.03%	120.43%	559.05%	678.17%	82.30%	31.06%	25.77%	14.88%	Upgrade
EPS (Basic)	-7.73	-20.74	-21.90	-12.90	-75.60	-33.90	24.30	-1035.00	-3447.00	-4950.01	Upgrade
EPS (Diluted)	-7.73	-20.74	-21.90	-12.90	-75.60	-33.90	24.30	-1035.00	-3447.00	-4950.01	Upgrade
Free Cash Flow	-23.91	-61.6	-49	-20.91	-19.31	-1.58	-10.47	-13.08	-22.97	-18.6	Upgrade
Free Cash Flow Per Share	-4.88	-17.37	-16.17	-14.02	-28.52	-15.39	-792.88	-1806.80	-4157.90	-4232.51	Upgrade
Gross Margin	100.00%	-	-	-	100.00%	-	-	-	80.95%	90.09%	Upgrade
Operating Margin	-1838.36%	-	-	-	-7932.53%	-	-	-	-441.21%	-244.18%	Upgrade
Profit Margin	-1719.56%	-	-	-	-13668.00%	-	-	-	-393.12%	-235.30%	Upgrade
Free Cash Flow Margin	-1085.43%	-	-	-	-5148.00%	-	-	-	-474.77%	-200.83%	Upgrade
EBITDA	-37.75	-73.47	-64.45	-18.94	-51.23	-3.34	0.52	-6.34	-17.83	-21.28	Upgrade
EBITDA Margin	-1713.57%	-	-	-	-13660.27%	-	-	-	-368.42%	-229.80%	Upgrade
Depreciation & Amortization	0.06	0.05	0	0	0	0	0.12	0.11	0.3	0.17	Upgrade
EBIT	-37.81	-73.52	-64.45	-18.94	-51.23	-3.34	0.4	-6.45	-18.13	-21.45	Upgrade
EBIT Margin	-1716.16%	-	-	-	-13660.27%	-	-	-	-374.62%	-231.63%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).